College of Medicine and Health interdisciplinary Seed Awards (CiSA) 2021
The second CiSA seed funding scheme is being made available by the UCC College of Medicine and Health (CoMH) to provide an opportunity for new research collaborations between CoMH staff in the member Schools (Clinical Therapies, Dentistry, Medicine, Nursing and Midwifery, Pharmacy and Public Health) and all healthcare aligned staff in affiliated clinical institutions.
Scope: The remit of CiSA is to promote collaborative translational research within the UCC CoMH and affiliated healthcare aligned services. It is envisaged that in particular, CiSA will facilitate the development of clinical and non-clinical researcher collaborations across all CoMH Schools and affiliated healthcare aligned services. Funding should be used to develop new or substantially new research areas, and to foster them to a point where a more extensive grant application can be made. It is not intended for existing, well-established collaborations where researchers have significant funding already in place.
Funding: up to €10,000
Duration: up to 1 year
Opening: March 15 2021
Deadline: August 16 2021 (Outcomes: October 01 2021)
This funding opportunity within the CoMH is available thanks to the generous philanthropic support of the CoMH industry partners (Boston Scientific, GSK, Laya Healthcare, and Pfizer). A maximum of six awards of €10,000 will be made available to support projects for a maximum duration of one year. A maximum two awards will be made to any one School. Awards will be made by the CoMH Research Committee on the basis of merit, with due regard to the College's aims under Athena Swan and cross-disciplinary research. The CoMH Research Committee will review applications
Application form and Guidelines are available from Dr Ashleigh Byrne on firstname.lastname@example.org.
Where ethical approval is required, applicants are advised to contact the relevant committee(s) in advance of submission of the completed application. Applicants are encouraged to have ethical approval (if required) in place before submission of the application form
2020 CiSA awards
Dr Margaret Curtin, Dr Claire Hayes, Dr Maria O'Shea and Dr Olga Buckley who represent the School of Nursing and Midwifery and Paediatric Haematology Oncology unit of the Mercy University Hospital – Qualitative Evaluation of a Paediatric Haematology Oncology Outreach Service at Mercy University Hospital.
Dr Mark G. Rae and Dr Suzanne Timmons who represent the School of Medicine and the Department of Geriatrics in the Mercy University Hospital - How does cerebrospinal fluid from Alzheimer’s disease patients affect human cortical forebrain cerebroid form and function?
Mr Chris CH Lim, Mr Michael Ita, Dr Noel Fanning and Dr André Toulouse who represent the School of Medicine and the Departments of Neurosurgery and Radiology in CUH – Characterisation of serum and cerebrospinal fluid biomarkers of angiographic cerebral vasospasm (ACV) and delayed cerebral ischemia (DCI) in aneurysmal subarachnoid haemorrhage.
Dr Frances Shiely and Dr Eva long who represent the School of Public Health, the HRB-CRF-C and Department of Renal Medicine, CUH – The challenges of recruitment to a randomised trial registry – what information matters to the patient?
Dr Helen Kelly, Dr Mary O’Dwyer, Prof Nicole Muller and Ms. Shinann Buckley-O’Sullivan who represent the School of Clinical Therapies, Cork Kerry Community Healthcare, University Hospital Kerry and KIDS & CAMHS Kerry – Optimising the role of Speech and Language Therapists in Emergency Departments in the integrated care of older people who are frail: Development of a Study Protocol.
Prof Stephen Byrne, Dr Daniel Mullane and Ms. Laura Gleeson who represent the School of Pharmacy, CUH and Mallow General Hospital – Improving Patient Safety Culture in Maternity Care Services within the SSHWG.
Prof Barry Plant and Dr Martina Hayes who represent the School of Dentistry and the Adult Cystic Fibrosis Centre, CUH - Oral Health in Adults with Cystic Fibrosis.